Lincoln Pharmaceuticals Ltd
NSE:LINCOLN
Lincoln Pharmaceuticals Ltd
Interest Income Expense
Lincoln Pharmaceuticals Ltd
Interest Income Expense Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Lincoln Pharmaceuticals Ltd
NSE:LINCOLN
|
Interest Income Expense
-₹20.2m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
13%
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Interest Income Expense
-₹2.6B
|
CAGR 3-Years
-151%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Interest Income Expense
-₹655.8m
|
CAGR 3-Years
17%
|
CAGR 5-Years
19%
|
CAGR 10-Years
8%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Interest Income Expense
-₹3.2B
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
4%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Interest Income Expense
-₹2.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
10%
|
CAGR 10-Years
-6%
|
|
|
M
|
Mankind Pharma Ltd
NSE:MANKIND
|
Interest Income Expense
₹1.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Lincoln Pharmaceuticals Ltd
Glance View
Lincoln Pharmaceuticals Ltd. is a holding company, which engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat. The firm offers products, such as tablets, capsules, liquid injection, cream in tubes, dry power injection, liquid in bott, liquid injection and pharma products. The company has operations in cardiac, diabetic, anti-malarial, anti-biotics, cephalosporins, analgesic, antipyretics, vitamin-minerals and iron preparations, among others. The firm serves approximately 60 countries in Europe, Latin America, Africa, Asia Pacific, Southeast Asia and 26 States across India. The firm's products include ARHL Tablet (used to treat chloroquine resistant falciparum malaria symptoms), Ibuprofen Tablet (used to treat pain, fever, and inflammation), Dolomol Tablet (used to treat aches and pains), Namcold Tablet (used to treat common cold symptoms) and Tinnex Capsule used to treat tinnitus.
See Also
What is Lincoln Pharmaceuticals Ltd's Interest Income Expense?
Interest Income Expense
-20.2m
INR
Based on the financial report for Dec 31, 2024, Lincoln Pharmaceuticals Ltd's Interest Income Expense amounts to -20.2m INR.
What is Lincoln Pharmaceuticals Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
13%
Over the last year, the Interest Income Expense growth was 5%. The average annual Interest Income Expense growth rates for Lincoln Pharmaceuticals Ltd have been -11% over the past three years , 10% over the past five years , and 13% over the past ten years .
You don't have any saved screeners yet